{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T05:08:16Z","timestamp":1765602496164,"version":"3.48.0"},"reference-count":23,"publisher":"BMJ","issue":"6","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Finnish Cancer Organization"},{"DOI":"10.13039\/501100004012","name":"Jane ja Aatos Erkon S\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004012","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2022,5,13]]},"published-print":{"date-parts":[[2022,6]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>\n                      We assessed the relationship between\n                      <jats:italic>Chlamydia trachomatis<\/jats:italic>\n                      infection, duration of oral contraceptive (OC) use and cervical atypia among young adult Finnish women.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>A longitudinal study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Setting and participants<\/jats:title>\n                    <jats:p>\n                      Women who were included in this study participated in a community-randomised trial on the effectiveness of human papillomavirus (HPV) vaccination and\n                      <jats:italic>C. trachomatis<\/jats:italic>\n                      screening at ages 18.5 and 22 years in Finland. They completed questionnaires on both visits about sexual behaviours. The cytology test results at age 18.5 and 22 years were also available for those women. The total number of participants in this study at 18.5 years of age were 11 701 and at 22 years of age were 6618.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Main outcome measure<\/jats:title>\n                    <jats:p>\n                      ORs with 95% CIs using univariable and multivariable logistic regression were used to assess the association between\n                      <jats:italic>C. trachomatis<\/jats:italic>\n                      infection, duration of OC and squamous intraepithelial lesions (SIL).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      There were 940 cytological SIL cases at the first screening visit and 129 cytological SIL cases at the second screening visit. Among the 22 years old, more than fourfold adjusted risk of SIL was associated with\n                      <jats:italic>C. trachomatis<\/jats:italic>\n                      positivity. The HPV16\/18, condom use, smoking and number of sexual partners adjusted joint effect of prolonged OC use and\n                      <jats:italic>C. trachomatis<\/jats:italic>\n                      was significantly increased (OR 4.7, 95% CI 1.7 to 12.8) in the 22-year-old women. This observed joint effect was 1.6 times higher than expected on a multiplicative scale. On additive scale, the observed relative excess risk from interaction was 1.8.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      The risk of SIL in HPV vaccinated women is significantly increased if they are\n                      <jats:italic>C. trachomatis<\/jats:italic>\n                      positive and have used OC for 5 or more years. The biological basis may be lack of condom facilitated protection against sexually transmitted diseases.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration number<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"clintrialgov\" xlink:href=\"NCT00534638\">NCT00534638<\/jats:ext-link>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2021-056824","type":"journal-article","created":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T13:01:56Z","timestamp":1654088516000},"page":"e056824","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":5,"title":["Association of\n                    <i>Chlamydia trachomatis<\/i>\n                    infection with cervical atypia in adolescent women with short-term or long-term use of oral contraceptives: a longitudinal study in HPV vaccinated women"],"prefix":"10.1136","volume":"12","clinical-trial-number":[{"clinical-trial-number":"nct00534638","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8679-286X","authenticated-orcid":false,"given":"Indira","family":"Adhikari","sequence":"first","affiliation":[{"name":"Faculty of Social Sciences, Tampere University, Tampere, Finland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tiina","family":"Eriksson","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Tampere University, Tampere, Finland"},{"name":"FICAN-Mid, Tampere, Finland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katja","family":"Harjula","sequence":"additional","affiliation":[{"name":"FICAN-Mid, Tampere, Finland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mari","family":"Hokkanen","sequence":"additional","affiliation":[{"name":"FICAN-Mid, Tampere, Finland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Apter","sequence":"additional","affiliation":[{"name":"VL-Medi, Helsinki, Finland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pekka","family":"Nieminen","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Helsinki University Hospital and Helsinki University, Helsinki, Finland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3231-8550","authenticated-orcid":false,"given":"Tapio","family":"Luostarinen","sequence":"additional","affiliation":[{"name":"Finnish Cancer Registry, Helsinki, Finland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matti","family":"Lehtinen","sequence":"additional","affiliation":[{"name":"FICAN-Mid, Tampere, Finland"},{"name":"Department of Laboratory Medicine, Karolinska Institute, Stockholm, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2022,6,1]]},"reference":[{"key":"2025121221060742000_12.6.e056824.1","doi-asserted-by":"crossref","first-page":"S121","DOI":"10.1093\/infdis\/jiab017","article-title":"Chlamydia trachomatis, pelvic inflammatory disease, and epithelial ovarian cancer","volume":"224","author":"Paavonen","year":"2021","journal-title":"J Infect Dis"},{"key":"2025121221060742000_12.6.e056824.2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1986.03370130086029"},{"key":"2025121221060742000_12.6.e056824.3","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.20970"},{"key":"2025121221060742000_12.6.e056824.4","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwn354"},{"key":"2025121221060742000_12.6.e056824.5","doi-asserted-by":"publisher","DOI":"10.1136\/sti.2010.044354"},{"key":"2025121221060742000_12.6.e056824.6","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1002\/ijc.28173","article-title":"Order of HPV\/Chlamydia infections and cervical high-grade precancer risk: a case-cohort study","volume":"133","author":"Luostarinen","year":"2013","journal-title":"Int J Cancer"},{"key":"2025121221060742000_12.6.e056824.7","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.10639"},{"key":"2025121221060742000_12.6.e056824.8","doi-asserted-by":"publisher","DOI":"10.1001\/jama.285.1.47"},{"key":"2025121221060742000_12.6.e056824.9","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.20257"},{"key":"2025121221060742000_12.6.e056824.10","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)61684-5"},{"key":"2025121221060742000_12.6.e056824.11","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/j.vaccine.2014.12.019","article-title":"Characteristics of a cluster-randomized phase IV human papillomavirus vaccination effectiveness trial","volume":"33","author":"Lehtinen","year":"2015","journal-title":"Vaccine"},{"key":"2025121221060742000_12.6.e056824.12","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1002\/ijc.31119","article-title":"Impact of gender-neutral or girls-only vaccination against human papillomavirus-Results of a community-randomized clinical trial (I)","volume":"142","author":"Lehtinen","year":"2018","journal-title":"Int J Cancer"},{"key":"2025121221060742000_12.6.e056824.13","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1002\/ijc.31618","article-title":"Gender-Neutral vaccination provides improved control of human papillomavirus types 18\/31\/33\/35 through herd immunity: results of a community randomized trial (III)","volume":"143","author":"Lehtinen","year":"2018","journal-title":"Int J Cancer"},{"key":"2025121221060742000_12.6.e056824.14","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1002\/ijc.32802","article-title":"Baseline findings and safety of infrequent vs. frequent screening of human papillomavirus vaccinated women","volume":"147","author":"Louvanto","year":"2020","journal-title":"Int J Cancer"},{"key":"2025121221060742000_12.6.e056824.15","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1080\/13625187.2018.1431214","article-title":"The risk of cervical atypia in oral contraceptive users","volume":"23","author":"Adhikari","year":"2018","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"2025121221060742000_12.6.e056824.16","doi-asserted-by":"publisher","DOI":"10.1177\/1403494811421977"},{"key":"2025121221060742000_12.6.e056824.17","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1080\/14034940701269654","article-title":"Sexual health among young adults in Finland: assessing risk and protective behaviour through a general health survey","volume":"35","author":"Nikula","year":"2007","journal-title":"Scand J Public Health"},{"key":"2025121221060742000_12.6.e056824.18","doi-asserted-by":"publisher","DOI":"10.1136\/sti.77.3.154"},{"key":"2025121221060742000_12.6.e056824.19","doi-asserted-by":"publisher","DOI":"10.1067\/mob.2001.115862"},{"key":"2025121221060742000_12.6.e056824.20","first-page":"209","article-title":"Chlamydia trachomatis and oral contraceptive use: a quantitative review","volume":"68","author":"Cottingham","year":"1992","journal-title":"Genitourin Med"},{"key":"2025121221060742000_12.6.e056824.21","doi-asserted-by":"crossref","first-page":"474.e1","DOI":"10.1016\/j.ajog.2007.03.032","article-title":"Women at risk for sexually transmitted diseases: correlates of intercourse without barrier contraception","volume":"197","author":"Peipert","year":"2007","journal-title":"Am J Obstet Gynecol"},{"key":"2025121221060742000_12.6.e056824.22","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)12949-2"},{"key":"2025121221060742000_12.6.e056824.23","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)08150-3"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2021-056824","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T05:06:13Z","timestamp":1765602373000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2021-056824"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":23,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2022,6,1]]},"published-print":{"date-parts":[[2022,6]]}},"alternative-id":["10.1136\/bmjopen-2021-056824"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2021-056824","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"type":"print","value":"2044-6055"},{"type":"electronic","value":"2044-6055"}],"subject":[],"published":{"date-parts":[[2022,6]]}}}